Risk factor
Low price volatility
Profitability factor
Very strong margins and returns
About
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic models and 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair value on EV/E
Target Price
The average target price of MOVE.SW is 163 and suggests 5% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell